DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Subotnik KL, Casaus LR, Ventura J. et al.
Long-acting injectable risperidone for relapse prevention and control of
breakthrough symptoms after a recent first episode of schizophrenia a randomized
clinical trial.
JAMA Psychiatry 2015;
72: 822-829
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.